Skip to main content

c-Abl Products

c-Abl (Abelson murine leukemia viral homolog 1) is a cytosolic member of the ABL subfamily, protein tyrosine kinase family of enzymes. It is ubiquitously expressed, and participates in multiple processes such as cell migration, actin reorganization, DNA damage response and apoptosis. Human c-Abl (I-B) is 1149 amino acids (aa) in length. It is myristoylated on Gly2 and contains one SH3 domain (aa 80-140), an SH2 domain (aa 146-236), a protein kinase region (aa 261-512), three NLS's (aa 620-634; 726-739; 778-791), one DNA-binding region (aa 888-988), an NES motif (aa 1109-1119) and an actin F-binding domain (aa 1120-1149). There is one alternate splice form (I-A) that contains a 26 aa substitution for the N-terminal 45 amino acids. In chronic myelogenous leukemia, c-Abl is fused to the Bcr gene product, resulting in the production of a constitutively active tyrosine kinase.

Show More

64 results for "c-Abl" in Products

Back to Search Results
Apply

64 results for "c-Abl" in Products

c-Abl Products

c-Abl (Abelson murine leukemia viral homolog 1) is a cytosolic member of the ABL subfamily, protein tyrosine kinase family of enzymes. It is ubiquitously expressed, and participates in multiple processes such as cell migration, actin reorganization, DNA damage response and apoptosis. Human c-Abl (I-B) is 1149 amino acids (aa) in length. It is myristoylated on Gly2 and contains one SH3 domain (aa 80-140), an SH2 domain (aa 146-236), a protein kinase region (aa 261-512), three NLS's (aa 620-634; 726-739; 778-791), one DNA-binding region (aa 888-988), an NES motif (aa 1109-1119) and an actin F-binding domain (aa 1120-1149). There is one alternate splice form (I-A) that contains a 26 aa substitution for the N-terminal 45 amino acids. In chronic myelogenous leukemia, c-Abl is fused to the Bcr gene product, resulting in the production of a constitutively active tyrosine kinase.

Show More

Highly potent pan-Src/Bcr-Abl inhibitor

Applications: WB, Simple Western
Reactivity: Human

Potent and selective v-Abl tyrosine kinase inhibitor; also inhibits PDGFR and c-kit

Dual Src-Abl inhibitor; antiproliferative

Applications: IHC, WB, ICC/IF, Flow
Reactivity: Human, Mouse

Recombinant Monoclonal Antibody

Applications: EnzAct

Ras signaling inhibitor; inhibits Ack1 and GCK

BCR-ABL1 kinase PROTAC® Degrader

Src family kinase inhibitor; also inhibits c-Abl

Applications: IHC, WB, ICC/IF, IP
Reactivity: Human, Mouse
Applications: IHC, WB, ICC/IF
Reactivity: Human
Applications: IHC, ICC/IF
Reactivity: Human
Applications: IHC, ICC/IF
Reactivity: Human
Applications: WB
Reactivity: Human, Mouse, Rat
Applications: WB
Reactivity: Human, Mouse, Rat

Potent inhibitor of Abl T315l mutant and wild-type Abl kinases

Potent EGFR and VEGFR inhibitor

Potent and selective Src tyrosine kinase family inhibitor; anticancer; antiviral; orally bioavailable

Applications: WB
Reactivity: Human, Mouse, Rat

Potent multi-kinase and pan-Bcr-Abl inhibitor

Applications: IHC, ELISA, ICC/IF
Reactivity: Human
Applications: IHC, ELISA, ICC/IF
Reactivity: Human

Dual kinase inhibitor; inhibits PI 3-K family kinases

Selective allosteric inhibitor of Bcr-Abl; analog of GNF 2 (Cat. No. 4399)

Potent PDGFRα and PDGFRβ inhibitor; also inhibits c-Abl, Lck, c-Src and Fyn kinases

Results Per Page
5 10 25 50
/ 3